Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Clinical Usefulness of F-18 FDG PET/CT in Papillary Thyroid Cancer with Negative Radioiodine Scan and Elevated Thyroglobulin Level or Positive Anti-thyroglobulin Antibody

Clinical Usefulness of F-18 FDG PET/CT in Papillary Thyroid Cancer with Negative Radioiodine Scan... Nucl Med Mol Imaging (2016) 50:130–136 DOI 10.1007/s13139-015-0378-5 ISSN (print) 1869-3482 ORIGINAL ARTICLE ISSN (online) 1869-3474 Clinical Usefulness of F-18 FDG PET/CT in Papillary Thyroid Cancer with Negative Radioiodine Scan and Elevated Thyroglobulin Level or Positive Anti-thyroglobulin Antibody 1 1 1 Su Jung Choi & Kyung Pyo Jung & Sun Seong Lee & 1 1 2 Yun Soo Park & Seok Mo Lee & Sang Kyun Bae Received: 20 May 2015 /Revised: 16 September 2015 /Accepted: 2 October 2015 /Published online: 22 October 2015 Korean Society of Nuclear Medicine 2015 Abstract in the patients with positive PET/CT finding. The sensitivity, Purpose Elevated thyroglobulin (Tg) levels, along with a neg- specificity, PPV, NPV, and accuracy of F-18 FDG PET/CT for ative radioiodine scan, present a clinical problem for the diag- detectingrecurrence were 64 %,94%, 86%, 81%, and 83 %. nosis of recurrence in papillary thyroid cancer (PTC) patients. In the analysis of F-18 FDG PET/CT under ETS, the sensitiv- The purpose of this study was to assess (1) the usefulness of ity, specificity, PPV, NPV and accuracy was 64 %, 94 %, F-fluorodeoxyglucose (F-18 FDG) positron emission to- 88 %, 81 % and 83 %. Those under TSH suppression were http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Nuclear Medicine and Molecular Imaging Springer Journals

Clinical Usefulness of F-18 FDG PET/CT in Papillary Thyroid Cancer with Negative Radioiodine Scan and Elevated Thyroglobulin Level or Positive Anti-thyroglobulin Antibody

Loading next page...
 
/lp/springer-journals/clinical-usefulness-of-f-18-fdg-pet-ct-in-papillary-thyroid-cancer-7IZmlO9m2b

References (28)

Publisher
Springer Journals
Copyright
Copyright © 2015 by Korean Society of Nuclear Medicine
Subject
Medicine & Public Health; Nuclear Medicine; Imaging / Radiology; Orthopedics; Cardiology; Oncology
ISSN
1869-3474
eISSN
1869-3482
DOI
10.1007/s13139-015-0378-5
pmid
27275361
Publisher site
See Article on Publisher Site

Abstract

Nucl Med Mol Imaging (2016) 50:130–136 DOI 10.1007/s13139-015-0378-5 ISSN (print) 1869-3482 ORIGINAL ARTICLE ISSN (online) 1869-3474 Clinical Usefulness of F-18 FDG PET/CT in Papillary Thyroid Cancer with Negative Radioiodine Scan and Elevated Thyroglobulin Level or Positive Anti-thyroglobulin Antibody 1 1 1 Su Jung Choi & Kyung Pyo Jung & Sun Seong Lee & 1 1 2 Yun Soo Park & Seok Mo Lee & Sang Kyun Bae Received: 20 May 2015 /Revised: 16 September 2015 /Accepted: 2 October 2015 /Published online: 22 October 2015 Korean Society of Nuclear Medicine 2015 Abstract in the patients with positive PET/CT finding. The sensitivity, Purpose Elevated thyroglobulin (Tg) levels, along with a neg- specificity, PPV, NPV, and accuracy of F-18 FDG PET/CT for ative radioiodine scan, present a clinical problem for the diag- detectingrecurrence were 64 %,94%, 86%, 81%, and 83 %. nosis of recurrence in papillary thyroid cancer (PTC) patients. In the analysis of F-18 FDG PET/CT under ETS, the sensitiv- The purpose of this study was to assess (1) the usefulness of ity, specificity, PPV, NPV and accuracy was 64 %, 94 %, F-fluorodeoxyglucose (F-18 FDG) positron emission to- 88 %, 81 % and 83 %. Those under TSH suppression were

Journal

Nuclear Medicine and Molecular ImagingSpringer Journals

Published: Oct 22, 2015

There are no references for this article.